CDCA Weight-Based Dose TID

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)NCT04270682MIRMPhase 3Completed2023-07-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.